Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ekta Hasani"'
Autor:
Natasha B. Leighl, Ekta Hasani, Wei Xu, Chung Kwun Amy Wong, Xin Qiu, Sohaib Masroor, Amalia M Issa, Graham McFarlane, Natalie Rozanec, Abul Kalam Azad, Henrique Hon, Sinead Cuffe, Shabbir M.H. Alibhai, Kimberly Tobros, Bradley De Souza, Geoffrey Liu
Publikováno v:
Pharmacogenetics and genomics. 24(7)
Pharmacogenomics is gaining increasing importance in the therapeutics of cancer; yet, there is little knowledge of cancer patients' attitudes toward the use of pharmacogenomic testing in clinical practice. We carried out this study to explore cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28983755c29854c4c6bca2b172438dbd
https://pubmed.ncbi.nlm.nih.gov/24911662
https://pubmed.ncbi.nlm.nih.gov/24911662
Autor:
Bradley De Souza, Chung-Kwun Amy Wong, Nelson A. Atehortua, Ekta Hasani, Sohaib Masroor, Natalie Rozanec, Natasha B. Leighl, Wei Xu, Abul Kalam Azad, Amalia M Issa, Geoffrey Liu, Xin Qiu, Shabbir M.H. Alibhai, Henrique Hon, Sinead Cuffe, Graham McFarlane, Kimberly Tobros
Publikováno v:
Journal of Clinical Oncology. 30:13-13
13 Background: Pharmacogenomics is increasingly utilized in oncology; however, there is little knowledge concerning cancer patients’ or oncologists’ attitudes toward PGT decision-making in clinical practice. Methods: A broad cross-section of canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2719d7aa7e8b10e0a642b175f64186bd
https://doi.org/10.1200/jco.2012.30.34_suppl.13
https://doi.org/10.1200/jco.2012.30.34_suppl.13
Autor:
Sohaib Masroor, Ekta Hasani, Bradley De Souza, Wei Xu, Chung-Kwun Amy Wong, Kimberly Tobros, Geoffrey Liu, Xin Qiu, Abul Kalam Azad, Amalia M Issa, Natasha B. Leighl, Henrique Hon, Sinead Cuffe, Natalie Rozanec, Shabbir M.H. Alibhai, Graham McFarlane
Publikováno v:
Journal of Clinical Oncology. 30:6005-6005
6005 Background: PGT offers the potential to improve cancer therapy through the use of specialized tests that can predict the level of efficacy and/or toxicity of specific treatments in an individual. However, there is currently little knowledge conc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abe94d80a516b373cc08bfb6b7b8b7df
https://doi.org/10.1200/jco.2012.30.15_suppl.6005
https://doi.org/10.1200/jco.2012.30.15_suppl.6005